EXCiPACT CELEBRATES ITS 100TH CERTIFICATION OF PHARMACEUTICAL EXCIPIENT SUPPLIERS
Brussels, 17 December 2019 – Press Release
EXCiPACT asbl is celebrating the award of the 100th GMP and/or GDP Certificate by one of its
internationally recognised Certification Bodies to either a manufacturer and/or a distributor of
pharmaceutical excipients!
We are most grateful for the support of the regulators and of our seven partner Certification Bodies –
AENOR, AJA, Blue, Bureau Veritas, Certiquality, DQS and SGS – who have worked hard to help us achieve
this result sooner than expected. Their continued support will be needed to help us reach our next
target of 150 certificates!
Third-party certification in the pharma sector was in its infancy in 2014 when we became an
independent, non-profit organisation. We are proud of the positive contribution made by the EXCiPACT
Certification Scheme to (1) the reduction of the audit burden for both suppliers and users of pharma
excipients and (2) to the security of the pharma supply chain for the benefit of patients globally.
See the full details of all 100 certifications across seventeen countries
The President of EXCiPACT, Dr Iain Moore of Croda, says “I am honoured to be part of a passionate team of experts who designed, built and delivered EXCiPACT for the benefit of all stakeholders, including most critically, the patients. This huge milestone for EXCiPACT means our team can rightly beproud of their contributions. With their dedication I am sure more success will follow.”